DE69413554T2 - IMIDAZO [1,5-a] CHINOLINE ZUR BEHANDLUNG VON ANGSTZUSTÄNDEN UND SCHLAFSTÖRUNGEN - Google Patents

IMIDAZO [1,5-a] CHINOLINE ZUR BEHANDLUNG VON ANGSTZUSTÄNDEN UND SCHLAFSTÖRUNGEN

Info

Publication number
DE69413554T2
DE69413554T2 DE69413554T DE69413554T DE69413554T2 DE 69413554 T2 DE69413554 T2 DE 69413554T2 DE 69413554 T DE69413554 T DE 69413554T DE 69413554 T DE69413554 T DE 69413554T DE 69413554 T2 DE69413554 T2 DE 69413554T2
Authority
DE
Germany
Prior art keywords
treatment
pct
sleep disorders
chinoline
anxieties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69413554T
Other languages
English (en)
Other versions
DE69413554D1 (de
Inventor
Eric Jacobsen
Brink Ruth Ten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69413554D1 publication Critical patent/DE69413554D1/de
Publication of DE69413554T2 publication Critical patent/DE69413554T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
DE69413554T 1993-11-19 1994-10-27 IMIDAZO [1,5-a] CHINOLINE ZUR BEHANDLUNG VON ANGSTZUSTÄNDEN UND SCHLAFSTÖRUNGEN Expired - Fee Related DE69413554T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15540593A 1993-11-19 1993-11-19
US24255694A 1994-05-13 1994-05-13
PCT/US1994/012197 WO1995014020A1 (en) 1993-11-19 1994-10-27 IMIDAZO[1,5-a]QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS

Publications (2)

Publication Number Publication Date
DE69413554D1 DE69413554D1 (de) 1998-10-29
DE69413554T2 true DE69413554T2 (de) 1999-03-18

Family

ID=26852302

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413554T Expired - Fee Related DE69413554T2 (de) 1993-11-19 1994-10-27 IMIDAZO [1,5-a] CHINOLINE ZUR BEHANDLUNG VON ANGSTZUSTÄNDEN UND SCHLAFSTÖRUNGEN

Country Status (14)

Country Link
US (2) USRE35840E (de)
EP (1) EP0729469B1 (de)
JP (1) JP3516453B2 (de)
KR (1) KR100365082B1 (de)
CN (1) CN1067684C (de)
AT (1) ATE171453T1 (de)
AU (1) AU683507B2 (de)
CA (1) CA2174106C (de)
DE (1) DE69413554T2 (de)
DK (1) DK0729469T3 (de)
ES (1) ES2123836T3 (de)
NZ (1) NZ275314A (de)
SI (1) SI0729469T1 (de)
WO (1) WO1995014020A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6025996A (en) * 1995-06-15 1997-01-15 Pharmacia & Upjohn Company Use of imidazo{1,5-a}quinolones as neuroprotective agents
DE602006020545D1 (de) 2005-01-19 2011-04-21 Meiji Seika Kaisha Imidazothiazol-derivat und herstellungsverfahren dafür

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1278272A (en) * 1969-02-19 1972-06-21 Pfizer Ltd Substituted hexahydro-imidazoquinolines
DK155524C (da) * 1987-03-18 1989-09-11 Ferrosan As Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
JP3147902B2 (ja) * 1991-06-14 2001-03-19 ファルマシア・アンド・アップジョン・カンパニー イミダゾ〔１，５−ａ〕キノキサリン

Also Published As

Publication number Publication date
AU683507B2 (en) 1997-11-13
CN1067684C (zh) 2001-06-27
ES2123836T3 (es) 1999-01-16
NZ275314A (en) 1997-02-24
AU8089694A (en) 1995-06-06
WO1995014020A1 (en) 1995-05-26
CN1135753A (zh) 1996-11-13
EP0729469B1 (de) 1998-09-23
JP3516453B2 (ja) 2004-04-05
USRE35840E (en) 1998-07-07
JPH09505291A (ja) 1997-05-27
KR100365082B1 (ko) 2003-04-16
CA2174106C (en) 2005-06-28
DE69413554D1 (de) 1998-10-29
CA2174106A1 (en) 1995-05-26
EP0729469A1 (de) 1996-09-04
KR960705823A (ko) 1996-11-08
ATE171453T1 (de) 1998-10-15
SI0729469T1 (en) 1998-12-31
US5594140A (en) 1997-01-14
DK0729469T3 (da) 1999-06-14

Similar Documents

Publication Publication Date Title
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
NO995006D0 (no) Nye forbindelser
DE69507029T2 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
DE69625518T2 (de) Wirkstoff zur behandlung neurodegenerativer störungen
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
ATE334668T1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE59409735D1 (de) ALKOXYALKYLCARBAMATE VON IMIDAZO[1,2-a]PYRIDINEN
ATE159937T1 (de) 1,4-disubstituierte piperazine zur behandlung von asthma und entzündungen der atemwege
ES2006619A6 (es) Un metodo para preparar derivados de piridil-y pirimidil-piperazinas.
DE69413554D1 (de) IMIDAZO [1,5-a] CHINOLINE ZUR BEHANDLUNG VON ANGSTZUSTÄNDEN UND SCHLAFSTÖRUNGEN
ATE143946T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
ATE203671T1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
DE59309469D1 (de) Triazolochinazoline zur behandlung zentralnervöser erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee